Active — Not RecruitingNot Applicable

Glycemic Control, Type II Diabetes, Parathyroidectomy

United States80 participantsStarted 2023-02-27

Plain-language summary

The purpose of this study is to assess glycemic control after parathyroidectomy in patients with primary hyperparathyroidism and concomitant type 2 diabetes mellitus.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Study group: Consecutive patients older than 18 years old with concomitant PHPT and DM who will undergo PTX. The indications and need for surgery will be independent from the research team.
✓. Control group: Consecutive patients older than 18 years old with concomitant PHPT and DM who will not undergo PTX. The indications to forgo surgery will be independent from the research team.

Exclusion criteria

✕. Patients with recurrent or persistent PHPT will not be included.
✕. Patients who are included but have evidence of recurrent or persistent PHPT based on six-month laboratory workup will be excluded from the final analysis (\<5% expected)9.
✕. Patients with type 1 diabetes mellitus
✕. Patients with secondary and/or tertiary hyperparathyroidism

What they're measuring

Assess glycemic control after parathyroidectomy in patients with primary hyperparathyroidism and concomitant type 2 diabetes mellitus

Timeframe: 1 year

Trial details

NCT IDNCT05761743

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Primary Hyperparathyroidism trials